Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Henry Ford Hospital

Henry Ford Hospital in Detroit, Michigan, United States is listed as a site for 1,144 registered clinical trials, 343 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,144
Ongoing 343

This page covers the site record Henry Ford Hospital in Detroit, Michigan, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Henry Ford Hospital report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,144 trials counted.

  • Phase 1 61 trials
  • Phase 1/2 55 trials
  • Phase 2 301 trials
  • Phase 2/3 37 trials
  • Phase 3 370 trials
  • Phase 4 45 trials
  • Not applicable 170 trials
  • Observational 102 trials
  • Expanded access 2 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 343 trials
  • Completed 588 trials
  • Terminated 174 trials
  • Other 39 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 74

1994: 8 trials (Phase 3 6, Phase 2 1, Phase 1/2 1) 1995: 6 trials (Phase 3 3, Phase 2 2, Phase 1/2 1) 1996: 7 trials (Phase 3 4, Phase 2 2, Phase 1 1) 1997: 13 trials (Observational 2, Phase 3 5, Phase 2 5, Phase 1/2 1) 1998: 30 trials (Not applicable 1, Phase 3 10, Phase 2 16, Phase 1/2 2, Phase 1 1) 1999: 19 trials (Observational 1, Phase 3 5, Phase 2 11, Phase 1/2 2) 2000: 33 trials (Observational 2, Not applicable 2, Phase 3 12, Phase 2 12, Phase 1/2 2, Phase 1 3) 2001: 22 trials (Phase 3 1, Phase 2 18, Phase 1/2 3) 2002: 12 trials (Observational 2, Phase 3 3, Phase 2 6, Phase 1 1) 2003: 13 trials (Observational 1, Phase 4 1, Phase 3 7, Phase 2 4) 2004: 17 trials (Observational 2, Not applicable 1, Phase 3 6, Phase 2 6, Phase 1/2 1, Phase 1 1) 2005: 16 trials (Observational 1, Phase 3 8, Phase 2 4, Phase 1/2 1, Phase 1 2) 2006: 18 trials (Not applicable 2, Phase 4 2, Phase 3 10, Phase 2 3, Phase 1/2 1) 2007: 35 trials (Other 1, Observational 4, Not applicable 2, Phase 4 2, Phase 3 14, Phase 2/3 1, Phase 2 9, Phase 1/2 2) 2008: 29 trials (Observational 2, Not applicable 5, Phase 4 2, Phase 3 9, Phase 2 8, Phase 1/2 1, Phase 1 2) 2009: 28 trials (Observational 4, Not applicable 3, Phase 4 1, Phase 3 15, Phase 2 4, Phase 1/2 1) 2010: 31 trials (Observational 2, Not applicable 5, Phase 4 1, Phase 3 9, Phase 2 10, Phase 1/2 2, Phase 1 2) 2011: 47 trials (Observational 8, Not applicable 10, Phase 4 6, Phase 3 13, Phase 2/3 1, Phase 2 7, Phase 1/2 1, Phase 1 1) 2012: 30 trials (Observational 5, Not applicable 5, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 8, Phase 1/2 1, Phase 1 2) 2013: 35 trials (Observational 7, Not applicable 5, Phase 4 1, Phase 3 8, Phase 2/3 1, Phase 2 8, Phase 1/2 1, Phase 1 4) 2014: 56 trials (Observational 9, Not applicable 6, Phase 4 2, Phase 3 11, Phase 2/3 7, Phase 2 15, Phase 1/2 1, Phase 1 5) 2015: 50 trials (Observational 7, Not applicable 5, Phase 4 5, Phase 3 14, Phase 2/3 3, Phase 2 10, Phase 1/2 3, Phase 1 3) 2016: 55 trials (Observational 7, Not applicable 14, Phase 4 3, Phase 3 12, Phase 2/3 1, Phase 2 9, Phase 1/2 3, Phase 1 6) 2017: 74 trials (Observational 5, Not applicable 21, Phase 4 2, Phase 3 18, Phase 2/3 3, Phase 2 17, Phase 1/2 3, Phase 1 5) 2018: 54 trials (Observational 1, Not applicable 12, Phase 4 1, Phase 3 19, Phase 2/3 3, Phase 2 11, Phase 1/2 3, Phase 1 4) 2019: 69 trials (Observational 4, Not applicable 14, Phase 4 3, Phase 3 22, Phase 2/3 5, Phase 2 16, Phase 1/2 3, Phase 1 2) 2020: 62 trials (Observational 3, Not applicable 11, Phase 4 2, Phase 3 20, Phase 2/3 1, Phase 2 16, Phase 1/2 5, Phase 1 4) 2021: 59 trials (Observational 4, Not applicable 10, Phase 4 3, Phase 3 22, Phase 2/3 1, Phase 2 12, Phase 1/2 4, Phase 1 3) 2022: 48 trials (Observational 4, Not applicable 6, Phase 4 4, Phase 3 11, Phase 2/3 3, Phase 2 11, Phase 1/2 4, Phase 1 5) 2023: 49 trials (Observational 2, Not applicable 5, Phase 3 24, Phase 2/3 1, Phase 2 12, Phase 1/2 1, Phase 1 4) 2024: 52 trials (Observational 5, Not applicable 16, Phase 4 1, Phase 3 13, Phase 2/3 3, Phase 2 13, Phase 1/2 1) 2025: 36 trials (Observational 3, Not applicable 4, Phase 4 2, Phase 3 21, Phase 2/3 1, Phase 2 5)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 23
2025 36
2024 52
2023 49
2022 48
2021 59
2020 62
2019 69
2018 54
2017 74

Showing 10 of 33 years.

Start your 14-day trial Email me all 33 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,144 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 273 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 521 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF